# Weight loss drug reduces risk of COVID deaths – Recent study reveals a link between weight loss drug and decreased mortality due to COVID-19. – The drug, lorcaserin, is typically prescribed for weight loss in individuals with obesity. – Patients taking this drug had a significantly lower risk of dying from COVID-19 compared to those not taking the medication. ## Study findings Lorcaserin, a weight loss drug, has shown promising results in reducing the risk of death from COVID-19. In a recent study, individuals who were prescribed lorcaserin for weight loss were found to have a lower likelihood of mortality due to the virus. This discovery suggests a potential benefit of the drug beyond weight management. ## Implications for weight loss and COVID-19 The study highlights a potential correlation between weight loss interventions and improved outcomes in COVID-19 cases. Incorporating weight loss medications like lorcaserin into treatment plans may offer additional protection for individuals, especially those with obesity. Further research is needed to explore the mechanisms behind this association and to validate the findings on a larger scale. ## Conclusion: The connection between weight loss and COVID-19 outcomes underscores the importance of maintaining a healthy weight for overall well-being. If you are looking to prioritize your health through weight management, Mindful Evolution offers telehealth services for weight loss support and guidance. Contact us today at 954-639-9960 or visit our website at https://yourmindfulevolution.com to learn more. Weight loss disclaimer: Weight loss results may vary. Always consult with a healthcare provider before starting any weight loss program. Call or text us at 954-639-9960 for telehealth services available in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.